Source: Healio News
Heavy alcohol consumption contributed to a high number of cancer cases in 2020, according to data in The Lancet Oncology. However, moderate drinking contributed to nearly 1 in 7 alcohol-associated malignancies.
A report on the data was the top story in hematology/oncology last week.
Another top story was about the FDA approval of Darzalex Faspro (daratumumab and hyaluronidase-fihj, Janssen) for patients with relapsed multiple myeloma. It is the only subcutaneous anti-CD38 monoclonal antibody that is approved in combination with Pomalyst (pomalidomide, Bristol Myers Squibb) and dexamethasone.